Document is current
Any future updates will be listed below
-
Authors
Hussain, Rashad https://orcid.org/0000-0003-2830-9678
Tithof, Jeffrey https://orcid.org/0000-0003-2083-0901
Wang, Wei
Cheetham-West, Arokoruba
Song, Wei
Peng, Weiguo
Sigurdsson, Björn https://orcid.org/0000-0002-7484-7779
Kim, Daehyun
Sun, Qian
Peng, Sisi
Plá, Virginia https://orcid.org/0000-0002-5501-0789
Kelley, Douglas H. https://orcid.org/0000-0001-9658-2954
Hirase, Hajime https://orcid.org/0000-0003-3806-6905
Castorena-Gonzalez, Jorge A. https://orcid.org/0000-0001-5252-375X
Weikop, Pia https://orcid.org/0000-0002-8422-1702
Goldman, Steven A. https://orcid.org/0000-0002-5498-4303
Davis, Michael J.
Nedergaard, Maiken
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 10 October 2023
First Online: 15 November 2023
Competing interests
: S.A.G. is a part-time employee and stock holder of Sana Biotechnology, a cell therapy company; he is also a co-founder of CNS2, which has licensed relevant patents. None of the work described in this paper has been funded by those companies. The other authors declare no competing interests.
